Sylvia Heeneman Selected Research

Sylvia Heeneman Research Topics

Disease

28	Atherosclerosis 11/2017 - 07/2003
20	Atherosclerotic Plaque (Atheroma) 01/2017 - 09/2003
11	Inflammation (Inflammations) 01/2016 - 01/2003
8	Cardiovascular Diseases (Cardiovascular Disease) 05/2014 - 03/2007
6	Hemorrhage 01/2015 - 07/2004
6	Thrombosis (Thrombus) 01/2013 - 10/2003
3	Stroke (Strokes) 01/2016 - 06/2008
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2016 - 09/2003
3	Vascular Remodeling 01/2016 - 11/2004
3	Neoplasms (Cancer) 03/2014 - 05/2012
3	Aneurysm (Aneurysms) 03/2010 - 08/2007
2	Fibrosis (Cirrhosis) 12/2012 - 07/2003
2	Myocardial Infarction 12/2012 - 07/2005
2	Breast Neoplasms (Breast Cancer) 09/2009 - 02/2006
2	Heart Failure 08/2008 - 07/2003
2	Hypertrophy 08/2008 - 02/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 07/2008 - 02/2006
2	Hodgkin Disease (Hodgkin's Disease) 07/2008 - 02/2006
2	Pathologic Constriction (Stenosis) 02/2005 - 07/2004
1	Vascular Calcification 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Hyperplasia 01/2016
1	Carotid Artery Diseases 01/2016
1	Rupture 05/2014
1	Thrombophilia 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2012
1	Heart Diseases (Heart Disease) 12/2012
1	Type 2 Diabetes Mellitus (MODY) 06/2012
1	Cardiotoxicity 05/2012
1	Amyloidosis 05/2012
1	Proteinuria 12/2010
1	Vascular Diseases (Vascular Disease) 09/2009
1	Carcinogenesis 09/2008

Drug/Important Bio-Agent (IBA)

17	Apolipoproteins E (ApoE)IBA 01/2016 - 09/2003
11	LipidsIBA 11/2017 - 11/2004
11	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2003
5	CollagenIBA 03/2010 - 07/2003
4	Cathepsin KIBA 01/2016 - 09/2006
4	Peptide Hydrolases (Proteases)FDA Link 01/2015 - 01/2006
4	Pharmaceutical PreparationsIBA 10/2011 - 06/2005
3	CoagulantsIBA 01/2013 - 09/2010
3	Contrast MediaIBA 01/2013 - 03/2009
3	Cysteine Proteases (Cysteine Protease)IBA 03/2010 - 09/2006
3	Polytetrafluoroethylene (Teflon)FDA Link 06/2008 - 07/2004
2	FibrinIBA 01/2015 - 08/2009
2	IronIBA 01/2015 - 06/2012
2	Biomarkers (Surrogate Marker)IBA 05/2014 - 10/2007
2	AnticoagulantsIBA 01/2013 - 06/2009
2	Thrombin FDA Link 01/2013 - 06/2009
2	ApolipoproteinsIBA 01/2013 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010 - 05/2005
2	Tacrolimus (Prograf)FDA LinkGeneric 07/2010 - 06/2005
2	gadofosveset trisodium (MS 325)FDA Link 05/2010 - 03/2009
2	CholesterolIBA 03/2009 - 02/2006
2	C-Reactive ProteinIBA 07/2007 - 02/2006
2	CytokinesIBA 03/2007 - 06/2005
2	IntegrinsIBA 09/2005 - 05/2005
1	Nicotine FDA Link 01/2022
1	IvabradineIBA 01/2017
1	fluorocholineIBA 01/2016
1	Cathepsin CIBA 01/2015
1	Advanced Glycation End ProductsIBA 05/2014
1	Interleukin-8 (Interleukin 8)IBA 05/2014
1	Pyruvaldehyde (Methylglyoxal)IBA 05/2014
1	PolyphenolsIBA 05/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2013
1	AntioxidantsIBA 05/2013
1	prolyl-proline (Pro-Pro)IBA 01/2013
1	CalciumIBA 06/2012
1	ZincIBA 06/2012
1	IonsIBA 06/2012
1	MetalsIBA 06/2012
1	CopperIBA 06/2012
1	AlbuminsIBA 05/2012
1	von Willebrand FactorIBA 05/2012
1	Alkaline PhosphataseIBA 05/2012
1	Atorvastatin (Lipitor)FDA Link 10/2011
1	Clopidogrel (Plavix)FDA Link 10/2011
1	Drug CombinationsIBA 10/2011
1	CD40 Ligand (CD40L)IBA 10/2011
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 12/2010
1	Metalloproteases (Metalloproteinases)IBA 11/2010
1	DisintegrinsIBA 11/2010
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2010
1	Immunoglobulin G (IgG)IBA 07/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2010
1	oxidized low density lipoproteinIBA 07/2010
1	ElastinIBA 03/2010
1	Angiotensin IIIBA 03/2010
1	Factor XIIIaIBA 08/2009
1	AntithrombinsIBA 06/2009
1	Gadolinium DTPA (Magnevist)FDA Link 03/2009
1	Cadherins (E-Cadherin)IBA 09/2008
1	beta CateninIBA 09/2008

Therapy/Procedure

7	Radiotherapy 11/2017 - 02/2006
3	Carotid Endarterectomy 01/2016 - 07/2004
3	Therapeutics 10/2011 - 01/2003
1	Ligation 01/2016
1	Free Tissue Flaps 09/2009